Could simple supplements ease a rare lung disease?
NCT ID NCT06959251
Summary
This study is testing whether daily supplements of glycine and magnesium+thiamine can help people with primary ciliary dyskinesia (PCD), a rare lung disease. Over 60 participants will take one of the supplements, a combination, or a placebo for six months alongside their usual care. Researchers will check if the supplements reduce lung flare-ups, improve breathing, and enhance quality of life.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PRIMARY CILIARY DYSKINESIA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Instituto Nacional de Enfermedades Respiratorias
RECRUITINGMexico City, 14080, Mexico
Contact
Contact
Contact
Contact
Contact
Contact
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.